ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

198
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
bullishMeituan
18 Nov 2019 22:40

HK Connect Flows: Close Meituan/Elong Trade with a 14.5% Profit

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
346 Views
Share
10 Nov 2019 10:15

HSCEI Rebalance - The Names They Are a Changin'

The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes on Friday post market close....

Logo
519 Views
Share
09 Oct 2019 09:45

Innovent Biologics - Promising Phase I Results for Lung Cancer

In the recent 2019 World Conference on Lung Cancer held in Spain, Innovent Biologics reported preliminary results from a Phase I clinical trial on...

Logo
439 Views
Share
28 Sep 2019 10:37

HK Short Interest - Big Covering in Financials

We analyse the latest SFC data released Friday evening on short position reporting in Hong Kong for the week ended 20 September. Total short...

Logo
525 Views
Share
23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
395 Views
Share
x